A practical solution for dyspareunia in breast cancer survivors: A randomized controlled trial

Journal of Clinical Oncology

Volumn 33, Issue 30, 2015, Pages 3394-3400

  Goetsch, Martha F ^a   Lim, Jeong Y ^a   Caughey, Aaron B ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; LIDOCAINE; LUBRICATING AGENT; PLACEBO; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SILICONE; STEROID; ESTROGEN; LOCAL ANESTHETIC AGENT;

ADULT; AGED; ARTHRITIS; ARTICLE; ASSESSMENT OF HUMANS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; DYSPAREUNIA; FEMALE; FEMALE SEXUAL DISTRESS SCALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HUMAN; HUMIDIFIER; INTIMACY; MATURATION; METASTASIS; MYALGIA; OPEN STUDY; ORGASM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL FUNCTION; SEXUAL FUNCTION QUESTIONNAIRE; SEXUAL INTERCOURSE; SEXUAL SATISFACTION; TAMPON; VAGINA ATROPHY; VAGINA PH; VULVA; VULVAR VESTIBULE; BREAST TUMOR; COMPLICATION; DEFICIENCY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SURVIVOR;

ANESTHETICS, LOCAL; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; DYSPAREUNIA; ESTROGENS; FEMALE; HUMANS; LIDOCAINE; MIDDLE AGED; SURVIVORS;

EID: 84945199499     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.60.7366     Document Type: Article

References (31)

1. Mok K, Juraskova I, Friedlander M: The impact of aromatase inhibitors on sexual functioning: Current knowledge and future research directions. Breast 17:436-440, 2008
2. Ganz PA, Desmond KA, Leedham B, et al: Quality of life in long-term, disease-free survivors of breast cancer: A follow-up study. J Natl Cancer Inst 94:39-49, 2002
3. Davis SR, Panjari M, Robinson PJ, et al: Meno-pausal symptoms in breast cancer survivors nearly 6 years after diagnosis. Menopause 21:1075-1081, 2014
4. National Cancer Institute: Sexuality and Reproductive Issues (PDQ). Bethesda, MD, National Cancer Institute, 2013. http://www.ncbi.nlm.nih-.gov/pubmedhealth/PMH0032685/
5. Tympanidis P, Terenghi G, Dowd P: Increased innervation of the vulval vestibule in patients with vulvodynia. Br J Dermatol 148:1021-1027, 2003
6. Weström LV, Willén R: Vestibular nerve fiber proliferation in vulvar vestibulitis syndrome. Obstet Gyn 91:572-576, 1998
7. Bohm-Starke N, Hilliges M, Falconer C, et al: Increased intraepithelial innervation in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 46:256-260, 1998
8. Leclair CM, Goetsch MF, Li H, et al: Histopathologic characteristics of menopausal vestibulodynia. Obstet Gynecol 122:787-793, 2013
9. Goetsch MF, Lim JY, Caughey AB: Locating pain in breast cancer survivors experiencing dyspareunia: A randomized controlled trial. Obstet Gynecol 123:1231-1236, 2014
10. Dworkin RH, Turk DC, Wyrwich KW, et al: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain 9:105-121, 2008
11. Quirk FH, Heiman JR, Rosen RC, et al: Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 11:277-289, 2002
12. Derogatis LR, Clayton A, Lewis-D'Agostino D, et al: Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 5:357-364, 2008
13. Danielsson I, Torstensson T, Brodda-Jansen G, et al: EMG biofeedback versus topical lidocaine gel: A randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand 85:1360-1367, 2006
14. Harris PA, Taylor R, Thielke R, et al: Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377-381, 2009
15. [No authors listed]: Management of symptomatic vulvovaginal atrophy: 2013 position statement of the North American Menopause Society. Menopause 20:888-902, 2013
16. Ettinger B, Hait H, Reape KZ, et al: Measuring symptom relief in studies of vaginal and vulvar atrophy: The most bothersome symptom approach. Menopause 15:885-889, 2008
17. Haefner HK, Collins ME, Davis GD, et al: The vulvodynia guideline. J Low Genit Tract Dis 9:40-51, 2005
18. Stockdale CK, Lawson HW: 2013 Vulvodynia Guideline update. J Low Genit Tract Dis 18:93-100, 2014
19. Bohm-Starke N, Hilliges M, Falconer C, et al: Neurochemical characterization of the vestibular nerves in women with vulvar vestibulitis syndrome. Gynecol Obstet Invest 48:270-275, 1999
20. Robboy SJ, Bentley RC, Russell P: Embryology of the female genital tract and disorders of abnormal sexual development, in Kurman RJ (ed): Blaustein's Pathology of the Female Genital Tract (ed 5). New York, NY, Springer, 2002, p 12
21. Chakrabarty A, Liao Z, Smith PG: Angiotensin II receptor type 2 activation is required for cutaneous sensory hyperinnervation and hypersensitivity in a rat hind paw model of inflammatory pain. J Pain 14:1053-1065, 2013
22. Zoubina EV, Smith PG: Sympathetic hyperinnervation of the uterus in the estrogen receptor alpha knockout mouse. Neuroscience 103:237-244, 2001
23. Goetsch MF: Postpartum dyspareunia: An unexplored problem. J Reprod Med 44:963-968, 1999
24. Potts M, Short R: Ever since Adam and Eve: The Evolution of Human Sexuality. Cambridge, England, Cambridge University Press, 1999
25. Goetsch MF: Unprovoked vestibular burning in late estrogen-deprived menopause: A case series. J Low Genit Tract Dis 16:442-446, 2012
26. Leiblum S, Bachmann G, Kemmann E, et al: Vaginal atrophy in the postmenopausal woman: The importance of sexual activity and hormones. JAMA 249:2195-2198, 1983
27. Braunholtz DA, Edwards SJ, Lilford RJ: Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect". J Clin Epidemiol 54:217-224, 2001
28. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, et al: Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol 15:969-973, 1997
29. Lee YK, Chung HH, Kim JW, et al: Vaginal pH-balanced gel for the control of atrophic vaginitis among breast cancer survivors: A randomized controlled trial. Obstet Gynecol 117:922-927, 2011
30. Kingsberg SA, Wysocki S, Magnus L, et al: Vulvar and vaginal atrophy in postmenopausal women: Findings from the REVIVE (REal Women's VIews of Treatment Options for Menopausal Vaginal CHangEs) survey. J Sex Med 10:1790-1799, 2013
31. Foster DC, Kotok MB, Huang LS, et al: The tampon test for vulvodynia treatment outcomes research: Reliability, construct validity, and responsiveness. Obstet Gynecol 113:825-832, 2009